Adam Havey, EVP, Business Operations at Emergent BioSolutions Inc. (EBS), sold 35,326 shares at $60.15 ($2.1M) on 2018-10-15, disclosed to the SEC on 2018-10-17.
Open-market sale of $2.1M EBS by EVP, Business Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.03 | 6,165 | $370K | 17.3% |
| 2 | $60.03 | 6,165 | $370K | 17.3% |
| 3 | $60.15 | 6,165 | $371K | 17.3% |
| 4 | $60.15 | 6,165 | $371K | 17.3% |
| 5 | $60.67 | 661 | $40K | 1.9% |
| 6 | $61.50 | 6,165 |
| $379K |
| 17.7% |
| 7 | $63.50 | 3,840 | $244K | 11.4% |
| Total | $60.72 avg | 35,326 | $2.1M | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |